SCHEMBL17675434

SCHEMBL17675434

C=CC(=O)Nc1ccc2ncnc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 1.00
BTK Q06187 10/20 1.00
ERBB2 P04626 3/20 0.57
TEC P42680 1/20 0.57
TXK P42681 1/20 0.57
BLK P51451 1/20 0.57
BMX P51813 1/20 0.57
JAK3 P52333 1/20 0.57
ERBB4 Q15303 1/20 0.57
FYN P06241 3/20 0.50
SRC P12931 3/20 0.50
CHRNB2 P17787 1/20 0.50
CHRNB4 P30926 1/20 0.50
CHRNA3 P32297 1/20 0.50
CHRNA4 P43681 1/20 0.50
VCP P55072 1/20 0.48
FGFR1 P11362 1/20 0.47
F2 P00734 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675364 0.86 BTK (1.00) EGFRBTKERBB2TECTXK
SCHEMBL17675213 0.85 EGFR (0.79) EGFRBTKERBB2TECTXK
SCHEMBL17675352 0.85 EGFR (0.74) EGFRBTKERBB2TECTXK
SCHEMBL17675258 0.84 EGFR (1.00) EGFRBTKERBB2BLKBMX
SCHEMBL17683820 0.84 BTK (0.77) EGFRBTKERBB2TECTXK
SCHEMBL17683822 0.84 EGFR (0.72) EGFRBTKERBB2TECTXK
SCHEMBL17683838 0.84 EGFR (0.72) EGFRBTKERBB2TECTXK
SCHEMBL17675332 0.83 BTK (0.70) EGFRBTKCHRNB2CHRNB4CHRNA3
SCHEMBL17675211 0.82 BTK (0.79) EGFRBTKERBB2TECTXK
SCHEMBL17675311 0.80 BTK (0.66) EGFRBTKCHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed
WO-2016055982-A1 QUINOLINE AND QUINAZOLINE COMPOUNDS ACERTA PHARMA B.V. (NL) 2016-04-14 WO disclosed